see http://clinicaltrials.gov/ct2/show/record/NCT00617669 Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer
- 11/15/11 11/15/11 -
- 3/23/14 3/23/14 - Martin Dugas
- 8/10/14 8/10/14 - Martin Dugas
- 4/13/21 4/13/21 - Dr. rer. medic Philipp Neuhaus
- 9/20/21 9/20/21 -
- 9/28/21 9/28/21 - Sarah Riepenhausen
September 28, 2021
To request one please log in.
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility DRKS00005404 NCT00617669 Prostate Cancer
C0153690 (UMLS CUI-2)
C0392920 (UMLS CUI-2)
C0155626 (UMLS CUI [1,2])
C0036572 (UMLS CUI-2)